Pulse Biosciences (PLSE) EBITDA Margin (2021 - 2025)

Name: Pulse Biosciences (PLSE) EBITDA Margin (2021 - 2025) | Business Quant
Creator: Business Quant

Pulse Biosciences' quarterly EBITDA Margin came in at 22540.7% in Q3 2025, down 122.06% quarter-over-quarter from 102188.89% in Q4 2022.

Pulse Biosciences has reported EBITDA Margin for 3 years, with the latest figure at 22540.7% in Q3 2025.

For the quarter ending Q3 2025, EBITDA Margin changed N/A year-over-year to 22540.7%; the trailing twelve-month figure through Sep 2025 stood at 86898.84% (changed N/A YoY), and the FY2022 full-year result was 8357.86%, down 386851.0% from the prior year.
EBITDA Margin for Q3 2025 stood at 22540.7%, down from 102188.89% in the prior quarter.
The five-year high for EBITDA Margin was 102188.89% in Q4 2022, with the low at 22540.7% in Q3 2025.
Average EBITDA Margin over 3 years is 11129.64%, with a median of 3189.23% recorded in 2021.
Peak annual rise in EBITDA Margin reached 10401543 bps in 2022, while the deepest fall reached 10401543 bps in 2022.
Tracing PLSE's EBITDA Margin over 3 years: stood at 1826.54% in 2021, then soared by 5695 bps to 102188.89% in 2022, then plunged by 122 bps to 22540.7% in 2025.
The last three EBITDA Margin figures came in at 22540.7% (Q3 2025), 102188.89% (Q4 2022), and 4665.33% (Q2 2022), per Business Quant data.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBITDA Margin (Qtr)
1	Intuitive Surgical	156.17 Bn	151.78 Bn	1.83 Bn	28.86%
2	Becton Dickinson	41.51 Bn	40.49 Bn	2.15 Bn	1.97%
3	Resmed	30.43 Bn	28.77 Bn	890.98 Mn	34.92%
4	West Pharmaceutical Services	22.78 Bn	22.26 Bn	296.40 Mn	20.96%
5	Solventum	13.39 Bn	13.39 Bn	1.10 Bn	4.04%
6	Cooper Companies	12.33 Bn	12.20 Bn	695.20 Mn	19.85%
7	Align Technology	11.65 Bn	10.59 Bn	736.59 Mn	13.65%
8	Baxter International	9.81 Bn	7.77 Bn	891.00 Mn	2.44%
9	Aptargroup	7.39 Bn	7.19 Bn	351.91 Mn	17.48%
10	Pulse Biosciences	1.72 Bn	1.72 Bn	-	-

Download Data 🔒